Zurich Cantonal Bank
RPTP

Zurich Cantonal Bank’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Zurich Cantonal Bank’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,454
Closed -$31K – 2626
2016
Q3 		$31K Buy
3,454
+921
+36% +$6.55K ﹤0.01% 1998
2016
Q2 		$14K Hold
2,533
– – ﹤0.01% 2277
2016
Q1 		$12K Hold
2,533
– – ﹤0.01% 2316
2015
Q4 		$13K Buy
2,533
+1,701
+204% +$9.87K ﹤0.01% 2304
2015
Q3 		$5K Buy
+832
New +$10.2K ﹤0.01% 2413

Zurich Cantonal Bank's RPTP Position: Q4 2016 in Review

Zurich Cantonal Bank sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 3,454 shares — an estimated $31K sold.

Zurich Cantonal Bank first reported a position in RPTP in Q3 2015 and held it in 5 quarters. The position peaked at $31K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Zurich Cantonal Bank reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Zurich Cantonal Bank sold 3,454 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $31K.
  • Zurich Cantonal Bank first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2015 and held it in 5 quarters.
  • Zurich Cantonal Bank's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $31K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Zurich Cantonal Bank's 13F filing for Q4 2016, filed 10 Feb 2017.